Bone Biologics Corp financial data

Symbol
BBLG, BBLGW on Nasdaq
Location
2 Burlington Woods Drive,, Suite 100,, Burlington, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
AFH ACQUISITION X, INC. (to 9/15/2014)
Latest financial report
10-K - Q4 2024 - Feb 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.36K %
Debt-to-equity 7.94 % -84.9%
Return On Equity -119 % +49.7%
Return On Assets -110 % +29%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.27M shares +197%
Common Stock, Shares, Outstanding 2.95M shares +453%
Entity Public Float 1.57M USD -62.4%
Common Stock, Value, Issued 2.95K USD +453%
Weighted Average Number of Shares Outstanding, Basic 1.52M shares +477%
Weighted Average Number of Shares Outstanding, Diluted 1.52M shares +477%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 2.13M USD -69.2%
General and Administrative Expense 2.09M USD -17.1%
Operating Income (Loss) -4.22M USD +55.3%
Nonoperating Income (Expense) 107K USD -77.7%
Net Income (Loss) Attributable to Parent -4.11M USD +54%
Earnings Per Share, Basic -4.83 USD/shares +85.8%
Earnings Per Share, Diluted -4.83 USD/shares +85.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.19M USD +6.43%
Assets, Current 3.86M USD +3.31%
Assets 3.86M USD +3.31%
Liabilities, Current 378K USD -54.6%
Liabilities 378K USD -54.6%
Retained Earnings (Accumulated Deficit) -85M USD -5.08%
Stockholders' Equity Attributable to Parent 3.48M USD +19.9%
Liabilities and Equity 3.86M USD +3.31%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.3M USD +3.45%
Net Cash Provided by (Used in) Financing Activities 1.5M USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 2.95M shares +453%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 201K USD
Deferred Tax Assets, Valuation Allowance 21.7M USD +6.23%
Deferred Tax Assets, Gross 21.7M USD +6.23%
Deferred Tax Assets, Operating Loss Carryforwards 10.8M USD +12.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Additional Paid in Capital 88.5M USD +5.59%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%